Medico-economic Interest of Single-use Ancillary Efficiency® in Fitting a GMK® Total Knee Arthroplasty (TKA)
IMEDUU
1 other identifier
interventional
48
1 country
1
Brief Summary
Clinical studies on single-use ancillaries are still few; medico-economic benefits have to be assessed regarding their design and use. A foreseeable increase in the number of surgeries in the future, tends to change the techniques and consequently to question the medico-economic context. Single-use ancillaries attempt to provide solutions to today's imperatives and could be relevant from a global medico-economic point of view. For the moment, the conventional ancillaries for TKA are reused after sterilization. The objective of the study is to improve the fluidity of the intervention process with cost control.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 16, 2020
CompletedStudy Start
First participant enrolled
March 1, 2020
CompletedFirst Posted
Study publicly available on registry
March 9, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2023
CompletedMarch 9, 2020
March 1, 2020
3 years
January 16, 2020
March 6, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Mean production cost of the surgical intervention (total knee arthroplasty) each arm, from an hospital perspective, using a micro-costing approach with items reported in a eCRF
Mean production cost of the surgical intervention in each arm is calculated thanks to 2 steps : 1) Quantification of health resources consumed during the surgical intervention (transport, cleaning, reconditionning sterilization of ancillaries, time spent by medical staff, nurses and materials used. (These data will be collected on a paper sheet and reported in a eCRF for 20 patients (10 per group)) ; 2) Valuation of health resources consumed with hospital cost accounting, mean wages, and purchase prices of materials.
Day 0
Secondary Outcomes (10)
Incremental cost-utility ratio comparing single use ancillary versus reusable ancillary
1 year
clinical functional result in each group (Total KSS score)
1 year postoperative
clinical functional result in each arm
3 months postoperative
HKA angle
1 year postoperative
HKA angle
3 months postoperative
- +5 more secondary outcomes
Study Arms (2)
Arm A: metallic reusable ancillary.
ACTIVE COMPARATORThis control group will be constituted of patients who will have the GMK® prosthesis with metallic reusable ancillary.
Arm B: Efficiency single use ancillary.
EXPERIMENTALThis group will be constituted of patients who will have the GMK® prosthesis with Efficiency single use ancillary.
Interventions
-For the Arm A, the surgical procedure of knee total arthroplasty will be done with metallic reusable ancillary. For the Arm B, the surgical procedure of knee total arthroplasty will be done with Efficiency single use ancillary.
Eligibility Criteria
You may qualify if:
- Patient with gonarthrosis or inflammatory arthrosis of the knee leading to surgical indication for total knee arthroplasty
- Informed patient, able to understand the information, not opposing to participate this protocol
- patient affiliate to social security
You may not qualify if:
- Extra-joint Deformation needing bone associated gesture
- Preoperative active or suspected infection
- Local evolutive tumoral pathology
- Medical history with bone gesture on concerned knee
- Patient unable or refusing to give his consentement
- Pregnant woman or in age to be pregnant without use any effective contraceptive method
- Patient under maintenance of justice, tutelage or legal guardianship)
- Presence of any family, sociological, political or geographic situation able to interfere with the protocol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Nantes University Hospitallead
- Medacta USAcollaborator
Study Sites (1)
CHU de Nantes (University Hospital of Nantes)
Nantes, France
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mike Persigant, MD
Nantes University Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 16, 2020
First Posted
March 9, 2020
Study Start
March 1, 2020
Primary Completion
March 1, 2023
Study Completion
March 1, 2023
Last Updated
March 9, 2020
Record last verified: 2020-03
Data Sharing
- IPD Sharing
- Will not share